Chrysin reduces inflammation and oxidative stress and improves ovarian function in D-gal-induced premature ovarian failure

References

• Laven JS. Primary Ovarian Insufficiency. Semin Reprod Med. 2016;34(4):230–234.
   PubMed Web of Science ®Google Scholar
• Lin J, Li XL, Song H, et al. A general description for Chinese medicine in treating premature ovarian failure. Chin J Integr Med. 2017;23:91–97.
   PubMed Web of Science ®Google Scholar
• Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015;42:153–161.
   PubMed Web of Science ®Google Scholar
• Sukur YE, Kivancli IB, Ozmen B. Ovarian aging and premature ovarian failure. J Turk Ger Gynecol Assoc. 2014;15(3):190–196.
   PubMedGoogle Scholar
• Fenton AJ. Premature ovarian insufficiency: pathogenesis and management. J Midlife Health. 2015;6:147–153.
   PubMedGoogle Scholar
• Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753–758.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588–1599.
   PubMed Web of Science ®Google Scholar
• Roeters van Lennep JE, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23:178–186.
   PubMed Web of Science ®Google Scholar
• Guerrero NV, Singh RH, Manatunga A, et al. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr. 2000;137:833–841.
   PubMed Web of Science ®Google Scholar
• Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65:963–975.
   PubMed Web of Science ®Google Scholar
• Moldogazieva NT, Mokhosoev IM, Mel’nikova TI, et al. Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases. Oxid Med Cell Longev. 2019;2019:3085756.
   PubMed Web of Science ®Google Scholar
• Rahimi VB, Askari VR, Mousavi SH. Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: a mechanistic study. Biomed Pharmacother. 2018;108:1712–1724.
   PubMed Web of Science ®Google Scholar
• Naz S, Imran M, Rauf A, et al. Chrysin: pharmacological and therapeutic properties. Life Sci. 2019;235:116797.
   PubMed Web of Science ®Google Scholar
• Souza LC, Antunes MS, Filho CB, et al. Flavonoid Chrysin prevents age-related cognitive decline via attenuation of oxidative stress and modulation of BDNF levels in aged mouse brain. Pharmacol Biochem Behav. 2015;134:22–30.
   PubMed Web of Science ®Google Scholar
• Rashno M, Sarkaki A, Farbood Y, et al. Therapeutic effects of chrysin in a rat model of traumatic brain injury: a behavioral, biochemical, and histological study. Life Sci. 2019;228:285–294.
   PubMed Web of Science ®Google Scholar
• He XL, Wang YH, Bi MG, et al. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats. Eur J Pharmacol. 2012;680:41–48.
   PubMed Web of Science ®Google Scholar
• Anand KV, Mohamed Jaabir MS, Thomas PA, et al. Protective role of chrysin against oxidative stress in d-galactose-induced aging in an experimental rat model. Geriatr Gerontol Int. 2012;12:741–750.
   PubMed Web of Science ®Google Scholar
• Mantawy EM, Said RS, Abdel-Aziz AK. Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: emphasis on TGF-beta/MAPKs signaling pathway. Biomed Pharmacother. 2019;109:293–303.
   PubMed Web of Science ®Google Scholar
• Bahrehbar K, Rezazadeh Valojerdi M, Esfandiari F, et al. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure. World J Stem Cells. 2020;12(8):857–878.
   PubMed Web of Science ®Google Scholar
• He L, Ling L, Wei T, et al. Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice. Exp Biol Med (Maywood). 2017;242(7):683–691.
   PubMed Web of Science ®Google Scholar
• Gao X, Qin T, Mao J, et al. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway. J Exp Clin Cancer Res. 2019;38(1):256.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Hirshfield AN, Midgley AR Jr. Morphometric analysis of follicular development in the rat. Biol Reprod. 1978;19:597–605.
   PubMed Web of Science ®Google Scholar
• Haddad YH, Said RS, Kamel R, et al. Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-beta, TGF-beta, and FOXL-2. Sci Rep. 2020;10:13551.
   PubMed Web of Science ®Google Scholar
• Qin Y, Guo T, Li G, et al. CSB-PGBD3 mutations cause premature ovarian failure. PLoS Genet. 2015; (11):e1005419. DOI:10.1371/journal.pgen.1005419.
   PubMedGoogle Scholar
• De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376(9744):911–921.
   PubMed Web of Science ®Google Scholar
• Ayres J. Premature menopause: management challenges after the Women’s Health Initiative. J Br Menopause Soc. 2005;11:157.
   PubMedGoogle Scholar
• Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol. 2008;24:273–279.
   PubMed Web of Science ®Google Scholar
• Prajit R, Sritawan N, Suwannakot K, et al. Chrysin protects against memory and hippocampal neurogenesis depletion in d-galactose-induced aging in rats. Nutrients. 2020;12.
   PubMed Web of Science ®Google Scholar
• Liao ZY, Liang IC, Li HJ, et al. Chrysin inhibits high glucose-induced migration on chorioretinal endothelial cells via VEGF and VEGFR down-regulation. Int J Mol Sci. 2020;21.
   Web of Science ®Google Scholar
• Banerjee S, Chakraborty P, Saha P, et al. Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression. PLoS One. 2012;7(2):e30709.
   PubMed Web of Science ®Google Scholar
• La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol (Oxf). 2006;64(6):603–610.
   PubMed Web of Science ®Google Scholar
• Wei JH, Yuan XY, Zhang JM, et al. Caspase activity and oxidative stress of granulosa cells are associated with the viability and developmental potential of vitrified immature oocytes. Eur J Obstet Gynecol Reprod Biol. 2016;198:22–26.
   PubMed Web of Science ®Google Scholar
• Tamura H, Takasaki A, Miwa I, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44(3):280–287.
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Finci-Yeheskel Z, Eldar I, et al. Serum amyloid A: expression throughout human ovarian folliculogenesis and levels in follicular fluid of women undergoing controlled ovarian stimulation. J Clin Endocrinol Metab. 2013;98(12):4970–4978.
   PubMed Web of Science ®Google Scholar
• Boots CE, Jungheim ES. Inflammation and Human Ovarian Follicular Dynamics. Semin Reprod Med. 2015;33:270–275.
   PubMed Web of Science ®Google Scholar
• Fu X, He Y, Xie C, et al. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy. 2008;10(4):353–363.
   PubMed Web of Science ®Google Scholar
• Chu YL, Xu YR, Yang WX, et al. The role of FSH and TGF-beta superfamily in follicle atresia. Aging (Albany NY). 2018;10:305–321.
   PubMedGoogle Scholar